Huihui Chen

Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study

Yihan Yao, Yunxiang Zhou, Shijie Wu, 2023, OncoTargets and therapy.

First‐line CDK4/6 inhibitor‐based combinations for HR+/HER2– advanced breast cancer: A Bayesian network meta‐analysis

Shijie Wu, Lu Shen, Xianan Guo, 2023, Journal of evidence-based medicine.